BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23552472)

  • 1. Expression and prognostic value of VEGFR-2, PDGFR-β, and c-Met in advanced hepatocellular carcinoma.
    Chu JS; Ge FJ; Zhang B; Wang Y; Silvestris N; Liu LJ; Zhao CH; Lin L; Brunetti AE; Fu YL; Wang J; Paradiso A; Xu JM
    J Exp Clin Cancer Res; 2013 Apr; 32(1):16. PubMed ID: 23552472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexpression of PDGFR-alpha, PDGFR-beta and VEGF as a prognostic factor in patients with hepatocellular carcinoma.
    Chen L; Shi Y; Jiang CY; Wei LX; Lv YL; Wang YL; Dai GH
    Int J Biol Markers; 2011; 26(2):108-16. PubMed ID: 21574155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinically relevant biomarkers to select patients for targeted inhibitor therapy after resection of hepatocellular carcinoma.
    Patel SH; Kneuertz PJ; Delgado M; Kooby DA; Staley CA; El-Rayes BF; Kauh JS; Sarmiento JM; Hanish S; Cohen C; Farris AB; Maithel SK
    Ann Surg Oncol; 2011 Nov; 18(12):3384-90. PubMed ID: 21590454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein expression profiling of vascular endothelial growth factor and its receptors identifies subclasses of hepatocellular carcinoma and predicts survival.
    Jia JB; Zhuang PY; Sun HC; Zhang JB; Zhang W; Zhu XD; Xiong YQ; Xu HX; Tang ZY
    J Cancer Res Clin Oncol; 2009 Jun; 135(6):847-54. PubMed ID: 19066962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and prognostic significance of vascular endothelial growth factor receptor 1 in hepatocellular carcinoma.
    Li T; Zhu Y; Qin CY; Yang Z; Fang A; Xu S; Ren W
    J Clin Pathol; 2012 Sep; 65(9):808-14. PubMed ID: 22734007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrasting prognostic implications of platelet-derived growth factor receptor-β and vascular endothelial growth factor receptor-2 in patients with angiosarcoma.
    Yonemori K; Tsuta K; Ando M; Hirakawa A; Hatanaka Y; Matsuno Y; Chuman H; Yamazaki N; Fujiwara Y; Hasegawa T
    Ann Surg Oncol; 2011 Oct; 18(10):2841-50. PubMed ID: 21409488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
    Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH
    Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemistry panel segregates molecular types of hepatocellular carcinoma in Brazilian autopsy cases.
    Felipe-Silva A; Wakamatsu A; Dos Santos Cirqueira C; Alves VA
    World J Gastroenterol; 2016 Jul; 22(27):6246-56. PubMed ID: 27468214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. u-PA and c-MET mRNA expression is co-ordinately enhanced while hepatocyte growth factor mRNA is down-regulated in human hepatocellular carcinoma.
    Tavian D; De Petro G; Benetti A; Portolani N; Giulini SM; Barlati S
    Int J Cancer; 2000 Sep; 87(5):644-9. PubMed ID: 10925356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic roles of cross-talk between peritumoral hepatocytes and stromal cells in hepatocellular carcinoma involving peritumoral VEGF-C, VEGFR-1 and VEGFR-3.
    Zhuang PY; Shen J; Zhu XD; Lu L; Wang L; Tang ZY; Sun HC
    PLoS One; 2013; 8(5):e64598. PubMed ID: 23737988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of PDGFR-α, EGFR and c-MET in spinal chordoma: a series of 52 patients.
    Akhavan-Sigari R; Gaab MR; Rohde V; Abili M; Ostertag H
    Anticancer Res; 2014 Feb; 34(2):623-30. PubMed ID: 24510991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleuro-pulmonary solitary fibrous tumors: a clinicopathologic, immunohistochemical, and molecular study of 88 cases confirming the prognostic value of de Perrot staging system and p53 expression, and evaluating the role of c-kit, BRAF, PDGFRs (alpha/beta), c-met, and EGFR.
    Schirosi L; Lantuejoul S; Cavazza A; Murer B; Yves Brichon P; Migaldi M; Sartori G; Sgambato A; Rossi G
    Am J Surg Pathol; 2008 Nov; 32(11):1627-42. PubMed ID: 18753943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-expression of PDGF-B and VEGFR-3 strongly correlates with poor prognosis in hepatocellular carcinoma patients after hepatectomy.
    Chen B; Liu J; Wang X; Shen Q; Li C; Dai C
    Clin Res Hepatol Gastroenterol; 2018 Apr; 42(2):126-133. PubMed ID: 29273278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-fetoprotein, vascular endothelial growth factor receptor-1 and early recurrence of hepatoma.
    Kamiyama T; Takahashi M; Nakanishi K; Yokoo H; Kamachi H; Kobayashi N; Ozaki M; Todo S
    World J Gastroenterol; 2012 Jan; 18(4):340-8. PubMed ID: 22294840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis.
    Geng M; Cao YC; Chen YJ; Jiang H; Bi LQ; Liu XH
    World J Gastroenterol; 2012 Mar; 18(12):1328-38. PubMed ID: 22493546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A survey of c-MET expression and amplification in 287 patients with hepatocellular carcinoma.
    Lee SJ; Lee J; Sohn I; Mao M; Kai W; Park CK; Lim HY
    Anticancer Res; 2013 Nov; 33(11):5179-86. PubMed ID: 24222167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma.
    Ueki T; Fujimoto J; Suzuki T; Yamamoto H; Okamoto E
    Hepatology; 1997 Apr; 25(4):862-6. PubMed ID: 9096589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-derived growth factor receptor α in hepatocellular carcinoma is a prognostic marker independent of underlying liver cirrhosis.
    Yu JH; Kim JM; Kim JK; Choi SJ; Lee KS; Lee JW; Chang HY; Lee JI
    Oncotarget; 2017 Jun; 8(24):39534-39546. PubMed ID: 28465473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis.
    Zhang QB; Jia QA; Wang H; Hu CX; Sun D; Jiang RD; Zhang ZL
    BMC Cancer; 2016 Nov; 16(1):880. PubMed ID: 27836008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of p53, mTOR, c-Met, IGF-1R, and HSP70 overexpression after the resection of hepatocellular carcinoma.
    Kang GH; Lee BS; Lee ES; Kim SH; Lee HY; Kang DY
    Gut Liver; 2014 Jan; 8(1):79-87. PubMed ID: 24516705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.